Rapport Therapeutics
About:
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Website: https://www.rapportrx.com
Top Investors: ARCH Venture Partners, Cormorant Asset Management, Fidelity, Perceptive Advisors, Sofinnova Investments
Description:
Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.
$250M
$1M to $10M
Boston, Massachusetts, United States
2022-01-01
David Bredt, Steven Paul
11-50
2023-08-23
Public
© 2025 bioDAO.ai